Brain scan study seeks clues to dystonia mystery
NCT ID NCT02727361
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how a specific brain chemical system (cholinergic) might be involved in dystonia, a condition causing muscle spasms and abnormal postures. Researchers used PET scans to measure chemical activity in the brains of 40 adults with a genetic form of dystonia (DYT1). The goal was to better understand the disease, not to test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSTONIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Bordeaux
Bordeaux, 33076, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can brain stimulation sharpen Decision-Making in Parkinson's?
- Personalized dosing for kids with dystonia? new study investigates genetic factors
- Blood test could spot Parkinson's earlier, study hopes
- Brain implant that thinks for itself tested in Parkinson's and dystonia
- New muscle relaxant drug MTR-601 tested in humans for first time